This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks.com highlights: Buckle, MasTec, ShotSpotter, Old Dominion Freight Line and Stryker
by Zacks Equity Research
Zacks.com highlights: Buckle, MasTec, ShotSpotter, Old Dominion Freight Line and Stryker
Winning Stock Picks from the Top 5 Industries with the Biggest Job Growth
by Kevin Matras
Kevin Matras goes over how to find winning stock-picking ideas in the government's 'boring' economic reports. Highlighted stocks include BKE, MTZ, SSTI, ODFL and SYK.
NuVasive's (NUVA) Global Prospects Solid, Competition Rife
by Zacks Equity Research
NuVasive (NUVA) demonstrates strong sales growth across all geographies. Competitive landscape is a concern.
The Zacks Analyst Blog Highlights: 3M, Altria, Stryker, UnitedHealth and Veeva
by Zacks Equity Research
The Zacks Analyst Blog Highlights: 3M, Altria, Stryker, UnitedHealth and Veeva
Top Stock Reports for 3M, Altria & Stryker
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including 3M (MMM), Altria (MO) and Stryker (SYK).
Why Is Stryker (SYK) Up 4.1% Since Its Last Earnings Report?
by Zacks Equity Research
Stryker (SYK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured expert Kevin Matras highlights: Waste Connections, Roper, Stryker and Hi-Crush
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Waste Connections, Roper, Stryker and Hi-Crush
Winning Stock Picks from the Top 4 Industries with the Biggest Job Growth
by Kevin Matras
Kevin Matras goes over how to find winning stock-picking ideas in the government's 'boring' economic reports. Highlighted stocks include WCN, ROP, SYK and HCLP.
Stryker (SYK) Q1 Earnings Beat Estimates, 2018 View Solid
by Zacks Equity Research
Stryker (SYK) gains from strong segmental show in Q1; a solid guidance is promising.
Medical Product Stock Earnings Roster for Apr 26: BAX & More
by Zacks Equity Research
Let's take a look at the factors that are likely to impact the earnings results of a few MedTech bigwigs within the broader Medical universe.